Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1

Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilin, Aleksandr I., Kulmanov, Murat E., Korotetskiy, Ilya S., Akhmetova, Gulshara K., Lankina, Marina V., Shvidko, Sergey V., Reva, Oleg N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2015
Materias:
Prokaryotes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645197/
https://www.ncbi.nlm.nih.gov/pubmed/26543112
http://dx.doi.org/10.1128/genomeA.01272-15
_version_ 1782400784110977024
author Ilin, Aleksandr I.
Kulmanov, Murat E.
Korotetskiy, Ilya S.
Akhmetova, Gulshara K.
Lankina, Marina V.
Shvidko, Sergey V.
Reva, Oleg N.
author_facet Ilin, Aleksandr I.
Kulmanov, Murat E.
Korotetskiy, Ilya S.
Akhmetova, Gulshara K.
Lankina, Marina V.
Shvidko, Sergey V.
Reva, Oleg N.
author_sort Ilin, Aleksandr I.
collection PubMed
description Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line anti-tuberculosis (TB) drugs under the influence of a new medicinal drug FS-1.
format Online
Article
Text
id pubmed-4645197
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-46451972015-11-20 Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1 Ilin, Aleksandr I. Kulmanov, Murat E. Korotetskiy, Ilya S. Akhmetova, Gulshara K. Lankina, Marina V. Shvidko, Sergey V. Reva, Oleg N. Genome Announc Prokaryotes Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line anti-tuberculosis (TB) drugs under the influence of a new medicinal drug FS-1. American Society for Microbiology 2015-11-05 /pmc/articles/PMC4645197/ /pubmed/26543112 http://dx.doi.org/10.1128/genomeA.01272-15 Text en Copyright © 2015 Ilin et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 3.0 Unported license (http://creativecommons.org/licenses/by/3.0/) .
spellingShingle Prokaryotes
Ilin, Aleksandr I.
Kulmanov, Murat E.
Korotetskiy, Ilya S.
Akhmetova, Gulshara K.
Lankina, Marina V.
Shvidko, Sergey V.
Reva, Oleg N.
Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
title Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
title_full Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
title_fullStr Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
title_full_unstemmed Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
title_short Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
title_sort complete genome sequence of multidrug-resistant clinical isolate mycobacterium tuberculosis 187.0, used to study the effect of drug susceptibility reversion by the new medicinal drug fs-1
topic Prokaryotes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645197/
https://www.ncbi.nlm.nih.gov/pubmed/26543112
http://dx.doi.org/10.1128/genomeA.01272-15
work_keys_str_mv AT ilinaleksandri completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1
AT kulmanovmurate completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1
AT korotetskiyilyas completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1
AT akhmetovagulsharak completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1
AT lankinamarinav completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1
AT shvidkosergeyv completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1
AT revaolegn completegenomesequenceofmultidrugresistantclinicalisolatemycobacteriumtuberculosis1870usedtostudytheeffectofdrugsusceptibilityreversionbythenewmedicinaldrugfs1

Ejemplares similares